Tag: life science

Nyheter

CYTO365 and Velit Biologics on top at regional Venture Cup Väst final

2012-05-16 14:09 CYTO365 won the “Best business plan"-award, at the Venture Cup Väst (West) regional final held in Gothenburg on 10 May. The company has patented a safe new valve, “CYTO365", which prevents thrombosis and air embolism in patients during chemotherapy treatment.Velit Biologics, develops SB101, a new cancer drug which chokes tumours by cutting off their nutrients via blood vessels.

Diabetes drug can prevent heart disease

2012-03-16 14:29 The widely used diabetes medicine metformin can have protective effects on the heart, reveals a new study conducted at the Sahlgrenska Academy. Researchers at the University of Gothenburg's Sahlgrenska Academy have shown in a preliminary study in rats that one of the most common diabetes drugs, metformin, also has a protective effect on the heart.

Immunicum includes first patients in phase l/ll of cancer vaccine study

2012-03-12 09:27 Immunicum develops vaccines for the therapeutic treatment of cancer. The Gothenburg-based company now includes the first patients in phase l/ll of cancer vaccine study. In total, 12 patients with metastasis cancer of the kidney are being treated in order to investigate possible side effects and the antitumour effect of the vaccine.

Large study in Gothenburg could save a lot of hearts

2012-02-23 16:59 The biggest research study of heart, lung and blood diseases ever to have been carried out in Sweden - SCAPIS - Swedish Cardiopulmonary Bioimage Study - was recently initiated in Gothenburg. A number of regional medical and healthcare operators are going to try and identify individual risk factors for heart attacks, sudden cardiac arrests and other heart diseases.

2012-02-15 09:41 Encubator AB has entered a new collaboration with AstraZeneca to facilitate the technical development of an AstraZeneca invention. The invention will be developed by Encubator together with Chalmers School of Entrepreneurship, and run as an innovation project with the aim of creating a new growth company.

New Swedish Implant Technique for the USA

2012-02-13 14:18 Bone-anchored prostheses for amputees are a pioneering method of treatment that significantly improves the quality of life for an important group of younger disabled individuals. The Gothenburg-based company Integrum recently presented the OPRA implant system — Osseointegrated Prosthetics for the Rehabilitation of Amputees, in the USA.

Revolutionary approach to allergy prevention

2012-02-10 13:55 Premune is based on world-leading research in bacteriology and immunology, with 15 years of clinical studies at the University of Gothenburg and Sahlgrenska Academy. Serendipity Innovations AB has initiated an exciting collaboration with Encubator AB regarding the startup company Premune AB, a company that is expected to revolutionize the market with its new approach to allergy prevention.

Gothenburg stem cell researcher awarded grant from Hjärnfonden (Swedish Brain Foundation)

2012-01-23 15:53 Hjärnfonden collects donations and supports research about the whole brain and nervous system. Charlotta Lindwall, at the University of Gothenburg, receives SEK 280,000 for her research into stem cells.

Iris Öhrn works for attracting foreign Life Science investments in Western Sweden

2012-01-13 07:30 Recently employed as Investment Manager for Life Science at Business Region Göteborg, Iris Öhrn works for making the Göteborg region and specifically our Life Science resources and competences better known abroad. "I will work for making our Life Science Industry clearer on the investors´ map," explains Iris Öhrn.

Transplantation research moves to Sahlgrenska Science Park

2012-01-03 12:17 Transplantation related research is being organised in a completely new way within Transplantation Biology & Regenerative Medicine at the Transplantation Centre at Sahlgrenska University Hospital in Göteborg. The new concept is based on the purpose of transferring knowledge from research to patient as quickly as possible. The center now moves to Sahlgrenska Science Park offering ideal premises.